PNE Delivered With a VR Headset in Outpatient LBP Patients

April 11, 2023 updated by: David Saul Binder, Spaulding Rehabilitation Hospital

Exploring the Feasibility and Acceptability of Pain Neuroscience Education Delivered With a Virtual Reality Headset to Outpatient Physical Therapy Patients Treated for Low Back Pain: a Pilot Multi-site Implementation Trial

The primary objective of this study is to explore the feasibility and acceptability of the delivery of educational content using a virtual reality headset in the setting of an outpatient physical therapy (PT) course of care for chronic low back pain. We aim to collect both qualitative and quantitative data regarding: 1) specifics of device use in the course of PT care 2) acceptability of both the content and delivery method from the therapist and subject perspective 3) subject attributes to characterize the study population and explore possible associations with content responses and 4) changes in pain knowledge from pre to post intervention. Information learned in this pilot study will assist us in 1) improving the content and delivery method of a chronic pain education program 2) implementing the program across the Spaulding rehabilitation network and 3) designing a more rigorous effectiveness trial.

Study Overview

Detailed Description

Study staff physical therapists will identify potential subjects upon completion of a standard physical therapy evaluation on patients referred for low back pain. Spaulding Outpatient sites in Malden, Quincy YMCA and Charlestown will participate.

  • Inclusion criteria: 1) pain lasting > 3 months and 2) > 18 years of age
  • Exclusion criteria: 1) inability to understand and communicate in English 2) inability to provide informed consent Individuals who meet the inclusion/exclusion criteria will receive an information study sheet, the full consent form for reference, and hear a brief explanation of the study from the treating study staff physical therapist. It will be emphasized that study participation is completely voluntary and refusal to participate will in no way impact their care at that clinic site or other MGB facilities either now or in the future.

SUBJECT ENROLLMENT

Once an eligible subject is identified, the evaluating study staff physical therapist will briefly introduce the study and provide the study information sheet and full consent form for review. Interested individuals will be contacted by phone by study staff. Study staff obtaining consent will discuss the details of the study with the individual using the full consent form and study information sheet as a guide and will cover all of the required elements of informed consent, including the purpose of the research, the study procedures, risks and benefits associated with participation, and answer study-related questions. Subjects will be advised that their clinical care will not be affected in any way if they decide to participate or decline participation, and that participation can be discontinued at any time. The principal investigator's and consenting study staff's contact information will be provided on the information sheet and consent form, and other study staff will provide their contact information as appropriate. The study will be explained in detail and the individual will be given the chance to ask any questions. Informed consent will be obtained verbally over the phone due to the minimal study risk, low study burden, and the necessity of limiting in-person contact. Study staff will document verbal consent by electronically signing a copy of the IRB approved telephone information consent document which will be electronically stored in a protected Dropbox file that only study staff will have access to. Paper consent forms will not be stored. A copy will be securely emailed via Outlook to the treating study staff physical therapist. This copy will be printed and provided to the subject in-person by the treating study staff physical therapist at the subject's next scheduled physical therapy visit.

Due to the minimal risk involved, informed consent may be given with less than 12 hours of notice, or they may be given additional time to consider.

STUDY PROCEDURES

Study staff physical therapists will be informed of enrollment. Once enrolled, subjects will complete the Keele STarT back questionnaire and a pain knowledge check. The pain education content will be delivered via the Oculus Go virtual reality (VR) headset at the beginning or end of the subjects scheduled PT appointments. There will be no added costs for content delivery and no additional study visits will be required outside of the regularly scheduled PT visits. Upon completing the pain education series, subjects will complete a feedback survey and a post-pain knowledge check. Study staff physical therapists will complete a survey for each enrolled subject.

Additionally, demographic information will be collected from the Epic electronic health record (EHR) such as: age, gender, educational level, relevant past medical history, results of relevant images, and pertinent physical therapy evaluation and treatment information that is standard of care for this patient population. This information will be used to characterize the study sample and begin to identify important attributes that may have more relevance regarding the response to the content.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lorna Brown, DPT

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02129
        • Spaulding Rehabilitation Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

chronic low back pain patients referred for outpatient physical therapy

Description

Inclusion Criteria:

  • pain lasting > 3 months
  • 18 years of age or older

Exclusion Criteria:

  • inability to understand and communicate in English
  • inability to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain knowledge and beliefs questionnaire
Time Frame: Through study completion; an average of 4 clinical sessions delivered over 2 to 4 weeks
assesses change in subject's knowledge and beliefs about pain
Through study completion; an average of 4 clinical sessions delivered over 2 to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Binder, MD, Spaulding Rehabilitation Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2021

Primary Completion (Actual)

August 31, 2022

Study Completion (Actual)

August 31, 2022

Study Registration Dates

First Submitted

February 22, 2021

First Submitted That Met QC Criteria

February 26, 2021

First Posted (Actual)

March 2, 2021

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021P000203

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Pain Neuroscience Education delivered via a Virtual Reality Headset

3
Subscribe